Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunodeficiency Syndrome”

7,798 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 7,798 results

Testing effectiveness (Phase 2)Study completedNCT00943540
What this trial is testing

Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients

Who this might be right for
HIV InfectionHIV Infections
Radboud University Medical Center 20
Large-scale testing (Phase 3)Study completedNCT00710060
What this trial is testing

Effectiveness of a Community-level HIV/STD Prevention Intervention in Promoting Safer Sexual Behaviors in High-risk Populations

Who this might be right for
HIV InfectionsSexually Transmitted Diseases
RTI International 18,147
Early research (Phase 1)Study completedNCT00001020
What this trial is testing

A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 28
Early research (Phase 1)Study completedNCT00902824
What this trial is testing

Safety and Immunogenicity of TBC-M4, a MVA HIV Vaccine Alone or in a Prime-Boost Regimen With ADVAX DNA HIV Vaccine

Who this might be right for
HIV Infections
International AIDS Vaccine Initiative 32
Testing effectiveness (Phase 2)WithdrawnNCT04720742
What this trial is testing

Immune Therapy and Analytical Treatment Interruption in HIV+ Participants Who Received an Allogeneic Stem Cell Transplantation

Who this might be right for
HIV Infection
IrsiCaixa
Large-scale testing (Phase 3)Study completedNCT01406470
What this trial is testing

Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency

Who this might be right for
Immunologic Deficiency Syndrome
Green Cross Corporation 45
Very early researchStudy completedNCT02431273
What this trial is testing

Safety and Pharmacokinetic Study of HIV Prophylaxis Using Antiretroviral Intravaginal Rings in Healthy Women

Who this might be right for
Human Immunodeficiency Virus (HIV) Prophylaxis
Auritec Pharmaceuticals 10
Not applicableStudy completedNCT04919018
What this trial is testing

Characterizing the Upper Airway Manifestations in Primary Ciliary Dyskinesia and Primary Immunodeficiencies

Who this might be right for
Primary Ciliary DyskinesiaKartagener SyndromePrimary Immune Deficiency
University of North Carolina, Chapel Hill 159
Large-scale testing (Phase 3)Ended earlyNCT00308620
What this trial is testing

Investigating the Anti-Human Immunodeficiency Virus (HIV) & Anti-inflammatory Effect of Chloroquine

Who this might be right for
HIV Infections
University of Minnesota 13
Large-scale testing (Phase 3)Active Not RecruitingNCT02881320
What this trial is testing

Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children With Human Immunodeficiency Virus-1

Who this might be right for
HIV-1 Infection
Gilead Sciences 177
Large-scale testing (Phase 3)Study completedNCT02032888
What this trial is testing

Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 238
Not applicableStudy completedNCT00691561
What this trial is testing

Culturally-Tailored HIV Risk Reduction for African-American MSM

Who this might be right for
HIV Infections
Medical College of Wisconsin 220
Not applicableStudy completedNCT00665561
What this trial is testing

Prospective Observational Epidemiologic Study of Maraviroc's Safety

Who this might be right for
Human Immunodeficiency Virus
ViiV Healthcare 2,500
Early research (Phase 1)Study completedNCT00024986
What this trial is testing

Tenofovir Disoproxil Fumarate to Treat Pediatric HIV

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 30
Post-approval studies (Phase 4)Study completedNCT01138215
What this trial is testing

The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children

Who this might be right for
HIV InfectionsVaricella-zoster Virus
The HIV Netherlands Australia Thailand Research Collaboration 60
Large-scale testing (Phase 3)Study completedNCT00456508
What this trial is testing

Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 147
Not applicableStudy completedNCT00782808
What this trial is testing

Peripheral Reservoir of HIV DNA in Monocytes Pivotal to Cognition in HIV

Who this might be right for
HIV Infections
SEARCH Research Foundation 60
Large-scale testing (Phase 3)Study completedNCT00242840
What this trial is testing

Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 20
Early research (Phase 1)Study completedNCT01056874
What this trial is testing

Effect Of Maraviroc On The Pharmacokinetics Of Digoxin

Who this might be right for
HealthyHIV Infections
ViiV Healthcare 12
Not applicableStudy completedNCT00002103
What this trial is testing

A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate (Neutrexin) With Leucovorin Protection for European Adult Patients (>= 13 Years Old) With Pneumocystis Carinii Pneumonia

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
U.S. Bioscience
Next Page